BioTime To Present At Oppenheimer Annual Healthcare Conference

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced that Adi Mohanty, Co-Chief Executive Officer, is scheduled to present at the Oppenheimer 26th Annual Healthcare Conference in New York City to be held on December 8-9, 2015. Mr. Mohanty will provide an overview of the Company and an update on product development in his presentation on December 8, 2015 at 3:55 pm ET/12:55 pm PT. Mr. Mohanty and Russell Skibsted, Chief Financial Officer, will also participate in one-on-one meetings with investors throughout the day.

Back to news